Patent · US Active

Anti-cancer combinations

US7863320B2 · kind B2 · utility

0Cited by
14References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2007
Grant dateJan 4, 2011
Priority date
Expiry dateJul 30, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a platinum compound which has anti-tumour activity. Preferably, the present invention relates to synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and carboplatin. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing such combinations. The invention further provides for methods of preparing the combinations of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.